| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152650 Methods and Compositions For Specifically Targeting Human Hepatocellular Carcinoma Cells |
| 06/26/2008 | US20080152647 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 06/26/2008 | US20080152645 Genetically Encoded Multifunctional Compositions Bidrectionally Transported Between Peripheral Blood and the CNS |
| 06/26/2008 | US20080152642 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/26/2008 | US20080152640 administering drugs comprising inhibitor of ATP-binding cassette transporters (ABC-transporter), such as verapamil or valspodar, for the treatment of arthritis; drug screening |
| 06/26/2008 | US20080152639 Using enzyme mixtures to control concentration of small leucine rich proteoglycans (SLRPs) and glycosaminoglycans in tissues and treat and prevent skin disorders |
| 06/26/2008 | US20080152638 Mixture comprising oxidoreductase and stability compounds for use in enhancing performance of cleaning solutions |
| 06/26/2008 | US20080152637 Methods of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152622 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 06/26/2008 | US20080152621 Antiviral nucleosides |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152619 Hepatitis C virus inhibitors |
| 06/26/2008 | US20080152618 Using tumor necrosis factor superfamily of ligands as therapeutic tool in treatment and prevention of cell proliferative disorders |
| 06/26/2008 | US20080152590 Engraftable Neural Progenitor and Stem Cells for Brain Tumor Therapy |
| 06/26/2008 | DE102006060344A1 Pharmazeutische Zusammensetzung, Verwendung der pharmazeutischen Zusammensetzung zur Behandlung eines Hirntumors, Herstellungsverfahren derselben sowie ein Kit of parts enthaltend die pharmazeutische Zusammensetzung Pharmaceutical composition, use of the pharmaceutical composition for the treatment of a brain tumor, manufacturing method thereof, and a kit of parts comprising the pharmaceutical composition |
| 06/26/2008 | CA2673484A1 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy |
| 06/26/2008 | CA2673421A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/26/2008 | CA2673222A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | CA2672973A1 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | CA2672772A1 Oral delivery of polypeptides |
| 06/26/2008 | CA2672758A1 Activin-actrii antagonists and uses for increasing red blood cell levels |
| 06/26/2008 | CA2672284A1 Human growth hormone formulations |
| 06/26/2008 | CA2671997A1 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 06/26/2008 | CA2671865A1 Canine thymic stromal lymphopoietin protein and uses thereof |
| 06/26/2008 | CA2671734A1 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935901A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/25/2008 | EP1935900A1 Peptides derived from colostrinin |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1935431A2 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 06/25/2008 | EP1935430A1 Modified coagulation factors with prolonged in vivo half-life |
| 06/25/2008 | EP1935429A1 Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates |
| 06/25/2008 | EP1935428A1 Oligonucleotide-polymer conjugates |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935416A2 Use of (Z)-2-cyano-3-Hydroxy-but-2-enoic acid-(4'-trifluorromethylphenyl)-amide for treating multiple sclerosis |
| 06/25/2008 | EP1934594A2 An animal model for studying atherosclerotic lesions |
| 06/25/2008 | EP1934341A1 Fusion proteins having a modulated half-life in plasma |
| 06/25/2008 | EP1934338A2 Protein kinase c peptide modulators of angiogenesis |
| 06/25/2008 | EP1934256A2 Hepatocyte growth factor receptor splice variants and methods of using same |
| 06/25/2008 | EP1934254A1 Y4 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1934253A2 Insulin receptor antagonists and related compositions, uses and methods |
| 06/25/2008 | EP1934250A2 Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| 06/25/2008 | EP1934245A1 Y2 selective receptor agonists for therapeutic interventions |
| 06/25/2008 | EP1933880A2 Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases |
| 06/25/2008 | EP1933877A2 Method of preparing a hydrogel |
| 06/25/2008 | EP1933863A2 Parathyroid hormone analogues and methods of use |
| 06/25/2008 | EP1933862A2 Methods and compositions for oral administration of proteins |
| 06/25/2008 | EP1933861A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 06/25/2008 | EP1933860A2 Treatment of optic neuritis |
| 06/25/2008 | EP1933859A2 Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| 06/25/2008 | EP1933855A1 Smooth muscle implant for managing a medical condition |
| 06/25/2008 | EP1933809A2 Compositions for nasal delivery |
| 06/25/2008 | EP1933767A2 Cell-free graft consisting of a matrix and a serum |
| 06/25/2008 | EP1658050B1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 06/25/2008 | EP1534313A4 Ophthalmologic irrigation solutions and method |
| 06/25/2008 | EP1485345B1 Urokinase inhibitors, production and use thereof |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | EP1425404B1 Vaccinia virus mva-e3l-knockout-mutants and use thereof |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1377164B1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | EP1325034B1 Pharmaceutically acceptable starch and manufacturing process thereof |
| 06/25/2008 | EP1322321B1 Use of S-[2,3-Bispalmitoyloxy-(2RS)-propyl]cysteinyl-GNNDESNISFKEK (MALP-2) |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP1230261B1 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1126874B2 Multicomponent meningococcal vaccine |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0851920B1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208429A Lipases for pharmaceutical use |
| 06/25/2008 | CN101208355A Treatment of fungal and/or protist infections |
| 06/25/2008 | CN101208106A Cancer therapeutic agent |
| 06/25/2008 | CN101208099A Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 06/25/2008 | CN101208098A Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 06/25/2008 | CN101205252A Soluble V E G F R bifunctional chimera receptor, preparation method and uses thereof |
| 06/25/2008 | CN101205251A Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof |
| 06/25/2008 | CN101204579A Application of regrouped human minute plasminogen on process for preparing the medicine curing eye disorders |
| 06/25/2008 | CN101204578A Extrasin combinationpreparation for immunomodulation, preventing tissue damage and reparative regeneration |
| 06/25/2008 | CN101204577A Process for preparing crystal composite of BTX-A |
| 06/25/2008 | CN101204576A Process for preparing cerebroprotein hydrolysate NaCl injection |
| 06/25/2008 | CN101204377A Novel cryoprotectants prescription for treatment of botulinum toxin a freeze-dried powder and injection preparation |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100397078C Method for identifying substances |
| 06/25/2008 | CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 06/25/2008 | CN100396701C Fusion protein of extrasin alpha1 and interferon |
| 06/25/2008 | CN100396700C Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses |
| 06/25/2008 | CN100396695C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/25/2008 | CN100396330C Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 06/25/2008 | CN100396329C Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical composition containing said suspension or aerosol, and their uses |